Researchers at the University of Wollongong have developed a new 3D bioprinter called the Pancreatic Islet Cell Transplantation (PICT) 3D Printer which can provide a newer treatment to patients of sever Type 1 Diabetes. The Bioprinter, developed by ARC Centre of Excellence for Electromaterials Science (ACES) and ANFF Materials, is capable of delivering insulin-producing islet cells from a protective bioink into a 3D printed scaffold that can be transplanted and prevent rejection risks.